CoChat

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

Open access
Norton, Elizabeth B., Lawson, Louise B., Freytag, Lucy C., Clements, John D. · 2011 · Clinical and Vaccine Immunology

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Despite the fact that the adjuvant properties of the heat-labile enterotoxins of Escherichia coli(LT) and Vibrio cholerae(CT) have been known for more than 20 years, there are no available oral vaccines containing these molecules as adjuvants, primarily because they are both very potent enterotoxins. A number of attempts with various degrees of success have been made to reduce or eliminate the enterotoxicity of LT and CT so they can safely be used as oral adjuvants or immunogens. In this report we characterize the structural, enzymatic, enterotoxic, and adjuvant properties of a novel mutant of LT, designated LT(R192G/L211A), or dmLT. dmLT was not sensitive to trypsin activation, had reduced enzymatic activity for induction of cyclic AMP in Caco-2 cells, and exhibited no enterotoxicity in the patent mouse assay. Importantly, dmLT retained the ability to function as an oral adjuvant for a coadministered antigen (tetanus toxoid) and to elicit anti-LT antibodies.In vitro and in vivo data suggest that the reduced enterotoxicity of this molecule compared to native LT or the single mutant, LT(R192G), is a consequence of increased sensitivity to proteolysis and rapid intracellular degradation in mammalian cells. In conclusion, dmLT is a safe and powerful detoxified enterotoxin with the potential to function as a mucosal adjuvant for coadministered antigens and to elicit anti-LT antibodies without undesirable side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cvi.00538-10

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Oplinger, 1997, Abstr. 37th Intersci. Conf. Antimicrob. Agents Chemother., abstr. G-10

Cited by

See all 221

Metadata

Authors
Norton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D.
Affiliations
Tulane University (US)
Corresponding author
Clements, John D.
Venue
Clinical and Vaccine Immunology
Published
2011-02-02
Volume
18
Issue
4
Pages
546-551
ISSN
  • 1556-679X (ISSN-L)
  • 1556-6811
OpenAlex
W2133080338
Cited by
221
References
40
Citations by year
2026: 5 · 2025: 14 · 2024: 2 · 2023: 25 · 2022: 8 · 2021: 10 · 2020: 13 · 2019: 14 · 2018: 20 · 2017: 17 · 2016: 20 · 2015: 17 · 2014: 18 · 2013: 17 · 2012: 16
FWCI
10.54
Type
journal article
Language
en
Open access
Locations
  • Clinical and Vaccine Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Louisiana Board of Regents
  • National Institutes of Health
  • National Institute of Biomedical Imaging and Bioengineering (EB006493-04, R01EB006493)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
heat-labile enterotoxin, Escherichia coli, oral adjuvant, trypsin activation, enterotoxicity, tetanus toxoid, mucosal immunization, intracellular degradation, proteolysis
MeSH terms
Adjuvants, Immunologic, Administration, Oral, Animals, Antibodies, Bacterial, Antitoxins, Bacterial Toxins, Enterotoxins, Female, Humans, Mice, Inbred BALB C, Tetanus Toxoid, Caco-2 Cells, Amino Acid Substitution, Escherichia coli Proteins, Mutant Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant. https://app.cochat.ai/papers/10.1128/cvi.00538-10
The paper
Norton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D. (2011). Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant. Clinical and Vaccine Immunology. https://doi.org/10.1128/cvi.00538-10

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.